custom image

Advances in Cancer Immunotherapy

August 17–19, 2020 | 10:00AM EDT | 2:00PM UTC | 4:00PM CEST*
*Program is subject to change

The American Association for Cancer Research (AACR) Publications Division is a proud sponsor of the Keystone eSymposia on Advances in Cancer Immunotherapy.

The AACR publishes 9 highly esteemed, peer-reviewed journals, covering advances in the causes, diagnosis, treatment, and prevention of cancer, including Cancer Immunology Research. This Journal provides a critical outlet for original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The mission of this Journal is to disseminate knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes. For pre-submission inquiries contact one of our in-house editors or read our instructions for authors.

Please check out the Resources tab or click on their titles to access complimentary article collections: Cancer Immunology Research Must-Read, Immunotherapy: Trials and Tribulations, and Toolbox: Coding and Computation.

Live chat

Must-Read Article Collection
Enjoy complimentary access to the Cancer Immunology Research Must-Read article collection for a limited time!
Immunotherapy: Trials and Tribulations

Enjoy complimentary access to this article collection for a limited time!

Toolbox: Coding and Computation

This collection is part of the Cancer Immunology Research editors’ “Toolbox” series, which highlights the most interesting platforms, methodologies, and prediction models recently published in the journal. In this collection, we have included articles that utilize machine learning algorithms or other computational methods to improve prediction modeling and identification of novel neoantigens, peptides, and cell types. We hope you enjoy this collection!